Search

Your search keyword '"Settleman J"' showing total 330 results

Search Constraints

Start Over You searched for: Author "Settleman J" Remove constraint Author: "Settleman J"
330 results on '"Settleman J"'

Search Results

1. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.

4. Structure, Activity, and Regulation of the Bovine Papillomavirus E5 Gene and Its Transforming Protein Product

5. EGFR-Mediated Chromatin Condensation Protects KRAS-Mutant Cancer Cells against Ionizing Radiation

6. p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4

11. Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

16. p190 RhoGAP, the major RasGAP-associated protein, binds GTP directly

39. SHP-2 Positively Regulates Myogenesis by Coupling to the Rho GTPase Signaling Pathway

40. Bovine papillomavirus mutant temperature sensitive for transformation, replication and transactivation.

41. Efficient transactivation and morphologic transformation by bovine papillomavirus genes expressed from a bovine papillomavirus/simian virus 40 recombinant virus.

42. Genetic evidence that acute morphologic transformation, induction of cellular DNA synthesis, and focus formation are mediated by a single activity of the bovine papillomavirus E5 protein

43. Myoblast city, the Drosophila homolog of DOCK180/CED-5, is required in a Rac signaling pathway utilized for multiple developmental processes.

44. Chromogranin, an integral membrane protein.

45. Relationship of multiple forms of chromogranin.

46. Bovine papillomavirus E2 gene regulates expression of the viral E5 transforming gene

48. Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells

49. Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug?

50. Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug?

Catalog

Books, media, physical & digital resources